| Zurich Market Talk - 01-02-2012 |
| 31.01.12 19:20 | |
|
The Roche Group posted strong operating results in a challenging market in 2011. Core operating profit grew faster than sales, and Core Earnings per Share increased by 11% at constant exchange rates (-4% in Swiss francs). The strengthening of the Swiss franc against major currencies, notably against the US dollar and the euro, had a significant negative impact on the results expressed in Swiss francs. Link: Click Here Novartis announced today that following a priority review, the US Food and Drug Administration (FDA) has approved an update to the Glivec (imatinib)* label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal trial. Link: Click Here Feintool sells IMA Automation Berlin to Mikron. Yesterday afternoon Feintool reached agreement with Mikron on the sale of automation specialist IMA Automation Berlin GmbH, based in Berlin, Germany, to the Swiss industrial group at the beginning of 2012. All 71 employees will transfer to Mikron. The deal will be finalized once the responsible competition authorities have given their approval. Link: Click Here Mikron expands automation business by acquiring IMA Automation Berlin. The Mikron Group will acquire IMA Automation Berlin GmbH from the Feintool Group with retroactive effect from 1 January 2012. Mikron Holding AG and Feintool International Holding AG agreed on the sale yesterday afternoon. IMA Berlin is a successful supplier of automation solutions for the automotive and solar industries. Link: Click Here Schweiter Technologies: Acquisition of Giudici completed. SSM Textile Machinery's acquisition of the activities of Giudici, announced on December 23, 2011, was closed as of January 31, 2012. The Giudici company is the leader in false-twist texturizing technology, a system for processing ultra-fine nylon yarn and similar materials. Link: Click Here The Kardex Group returned to profitability in 2011. Bookings increased by a significant 23% compared with the year-earlier figure (EUR 391 million) to EUR 480 million (adjusted for acquisitions 15%). At EUR 149 million, the order books were also well filled at the end of the year under review compared with 31 December 2010 (EUR 130.0 million). Link: Click Here Gurit achieved net sales of CHF 344.7 million for the full year 2011. In reported Swiss Francs this is an increase of 10.6%. At constant December 2011 translation rates a plus of 23.1%. On a currency and acquisition adjusted basis net sales grew by 19.2%. The Group EBIT margin is expected close to 9% and the operating EBIT margin excluding one-time effects close to 8%. Link: Click Here Roche (SIX: RO, ROG) announced today that it has provided notice to Illumina, Inc. (NASDAQ: ILMN) that it will nominate a slate of highly qualified, independent candidates for election to Illumina’s Board of Directors and propose certain other matters for the consideration of Illumina’s shareholders at Illumina’s 2012 annual meeting, which, if adopted, would result in Roche-nominated directors comprising a majority of the Illumina board. Link: Click Here Alpiq intends to sell its 20 percent stake in Edipower S.p.A. of Italy to Delmi for EUR 200 million. The Board of Directors of Alpiq Holding Ltd. has approved the sale to Delmi S.p.A. of the 20 percent stake in energy company Edipower S.p.A of Italy, at a price of EUR 200 million. The sale will take place within the framework of the transaction announced on 27 December 2011 by the parties involved in Edison and Edipower. Link: Click Here |
| < Prev | Next > |
|---|